143 related articles for article (PubMed ID: 37101189)
1. Trends in cause of death among patients with renal cell carcinoma in the United States: a SEER-based study.
Zhan X; Chen T; Liu Y; Wan H; Liu X; Deng X; Fu B; Xiong J
BMC Public Health; 2023 Apr; 23(1):770. PubMed ID: 37101189
[TBL] [Abstract][Full Text] [Related]
2. Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018.
Elgenidy A; Awad AK; Cheema HA; Shahid A; Kacimi SEO; Aly MG; Singla N; Afifi AM; Patel HD
Urol Oncol; 2023 Apr; 41(4):209.e11-209.e20. PubMed ID: 36822993
[TBL] [Abstract][Full Text] [Related]
3. Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.
Saad AM; Gad MM; Al-Husseini MJ; Ruhban IA; Sonbol MB; Ho TH
Clin Genitourin Cancer; 2019 Feb; 17(1):46-57.e5. PubMed ID: 30391138
[TBL] [Abstract][Full Text] [Related]
4. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
Kutikov A; Egleston BL; Wong YN; Uzzo RG
J Clin Oncol; 2010 Jan; 28(2):311-7. PubMed ID: 19933918
[TBL] [Abstract][Full Text] [Related]
5. Trends in the cause of death among patients with bladder cancer in the US SEER population, 1992-2018.
Zhan X; Chen L; Jiang M; Fu B
World J Urol; 2022 Jun; 40(6):1497-1503. PubMed ID: 35235018
[TBL] [Abstract][Full Text] [Related]
6. Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.
Castañeda-Avila MA; Ortiz-Ortiz KJ; Torres-Cintrón CR; Birmann BM; Epstein MM
Int J Cancer; 2020 Jan; 146(1):35-43. PubMed ID: 30802944
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
[TBL] [Abstract][Full Text] [Related]
8. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.
Shih YT; Xu Y; Chien CR; Kim B; Shen Y; Li L; Geynisman DM
Pharmacoeconomics; 2019 Dec; 37(12):1495-1507. PubMed ID: 31286464
[TBL] [Abstract][Full Text] [Related]
9. Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis.
Haifler M; Neheman A; Zisman A
Clin Genitourin Cancer; 2020 Aug; 18(4):e368-e373. PubMed ID: 32089472
[TBL] [Abstract][Full Text] [Related]
10. Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population-based study.
Zhan X; Chen L; Jiang M; Fu B
Cancer Med; 2022 Jun; 11(11):2308-2319. PubMed ID: 35238488
[TBL] [Abstract][Full Text] [Related]
11. Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.
Shuch B; Hofmann JN; Merino MJ; Nix JW; Vourganti S; Linehan WM; Schwartz K; Ruterbusch JJ; Colt JS; Purdue MP; Chow WH
Urol Oncol; 2014 Jan; 32(1):23.e9-13. PubMed ID: 23453468
[TBL] [Abstract][Full Text] [Related]
12. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
13. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients diagnosed with both melanoma and renal cell cancer.
Abern MR; Tsivian M; Coogan CL; Kaufman HL; Polascik TJ
Cancer Causes Control; 2013 Nov; 24(11):1925-33. PubMed ID: 23897487
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
[TBL] [Abstract][Full Text] [Related]
16. The Change Trend of Cause of Death in Patients With Stage I Non-Small Cell Lung Cancer After Surgery in US: A Long-Term Follow-Up Study Based on SEER Database.
Peng WD; Xie J; Zhang X; Li C
Cancer Control; 2020; 27(1):1073274820954461. PubMed ID: 33070629
[TBL] [Abstract][Full Text] [Related]
17. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
King SC; Pollack LA; Li J; King JB; Master VA
J Urol; 2014 Jun; 191(6):1665-70. PubMed ID: 24423441
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prognostic significance of second primary cancers in renal cell carcinoma.
Chakraborty S; Tarantolo SR; Batra SK; Hauke RJ
Am J Clin Oncol; 2013 Apr; 36(2):132-42. PubMed ID: 22441339
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
Barocas DA; Rabbani F; Scherr DS; Vaughan ED
BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
[TBL] [Abstract][Full Text] [Related]
20. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM
Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
